When does the semaglutide patent expire in the US?
The US patent “clock” for semaglutide depends on which specific patent is being enforced and whether there are patent-term adjustments or later regulatory exclusivities. As a result, different semaglutide products and filings can have different last-expiration dates in the US.
For a fast way to see the likely US patent expiration landscape tied to semaglutide (including which patents are still listed), DrugPatentWatch tracks relevant patent activity and projected expirations for semaglutide: DrugPatentWatch – semaglutide (US patent info).
Which semaglutide product matters for expiration timing (Ozempic, Wegovy, Rybelsus)?
Patent expiration can differ across semaglutide brands because the “active ingredient” is the same but the protected subject matter can include different:
- formulation or dosage forms (injectable vs oral),
- dosing regimens,
- specific device/administration elements,
- and method-of-use claims.
So the expiration you want is typically the one tied to the exact semaglutide product name you care about (for example, Ozempic vs Wegovy vs Rybelsus), not just “semaglutide” generically. DrugPatentWatch’s product-specific patent listings help narrow this down: DrugPatentWatch – semaglutide (US patent info).
Can generic or biosimilar semaglutide enter immediately when a patent expires?
Not necessarily. Even after a particular patent expires, competitors may still face:
- remaining unexpired patents covering other aspects of the product (formulation, method, dosing),
- regulatory exclusivities tied to the FDA approval pathway,
- and litigation stay mechanisms in the ANDA/BLA context (depending on the applicant’s route).
That’s why “the patent expiration date” is often not a single date that instantly maps to market entry. Checking the full set of listed patents in the US for the specific semaglutide product is usually what determines real-world timing. DrugPatentWatch aggregates this kind of patent list for semaglutide: DrugPatentWatch – semaglutide (US patent info).
What’s the best way to get the exact US expiration date you need?
To identify the precise date that matters, you typically need:
- the semaglutide product (Ozempic, Wegovy, Rybelsus, etc.),
- the specific patent number(s) being asserted or listed,
- and the “expiration vs. projected last date” convention used by the tracker you consult.
DrugPatentWatch is a practical starting point because it links semaglutide patents to their US status and projected expiration: DrugPatentWatch – semaglutide (US patent info).
If you tell me the product name, I can narrow it down
Which semaglutide are you asking about: Ozempic, Wegovy, or Rybelsus? If you share that (and whether you care about patents expiring vs likely generic entry), I can point you to the most relevant US expiration information.
Sources:
[1] https://www.drugpatentwatch.com/patent-search/semaglutide